Pages that link to "Q73618277"

The following pages link to The Preferential Induction of a Th1 Immune Response by DNA-Based Immunization Is Mediated by the Immunostimulatory Effect of Plasmid DNA (Q73618277):

Displaying 35 items.

• Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge (Q30307037) (← links)
• Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein. (Q31887780) (← links)
• Chimeric lyssavirus glycoproteins with increased immunological potential (Q33639069) (← links)
• Bacterial CpG DNA activates immune cells to signal infectious danger. (Q33683211) (← links)
• DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells (Q33767857) (← links)
• DNA and RNA-based vaccines: principles, progress and prospects (Q33783789) (← links)
• Modulation of host immune responses by protozoal DNA. (Q33805664) (← links)
• Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. (Q34001298) (← links)
• Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. (Q34001352) (← links)
• Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle (Q34004518) (← links)
• The role of CpG in DNA vaccines (Q34005441) (← links)
• Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae (Q34008890) (← links)
• Biological activity of immunostimulatory CpG DNA motifs in domestic animals (Q35051447) (← links)
• Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles (Q35181739) (← links)
• Technologies for enhanced efficacy of DNA vaccines (Q35802958) (← links)
• Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates (Q36438450) (← links)
• TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines (Q38331978) (← links)
• Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis (Q39463391) (← links)
• Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs? (Q40457531) (← links)
• Features of the antibody response attributable to plasmid backbone adjuvanticity after DNA immunization. (Q40788835) (← links)
• Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes (Q42251440) (← links)
• Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens. (Q44138330) (← links)
• HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens (Q44264951) (← links)
• Immune response and protection elicited by DNA immunisation against Taenia cysticercosis (Q44363586) (← links)
• Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli. (Q47711571) (← links)
• Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence (Q47872131) (← links)
• Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection (Q51050741) (← links)
• Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation (Q51070761) (← links)
• Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo (Q51801148) (← links)
• DNA vaccines for viral diseases (Q73265847) (← links)
• Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization (Q73980732) (← links)
• The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy (Q74100928) (← links)
• Immunotherapy prospects in tuberculosis: cytokines and DNA "vaccines" (Q74208943) (← links)
• Surface modified liposomes for nasal delivery of DNA vaccine (Q81038743) (← links)
• Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination (Q83916605) (← links)